Medical Affairs Intern: Obesity Insights and Education

Boehringer Ingelheim; Singapore; On-site; SGD 17,000 - 23,000; Full time

Job summary

Boehringer Ingelheim Singapore invites a full-time Contract for Service Intern to support regional medical education events for health care professionals and internal training. The role emphasizes insights analysis and desktop research on obesity, plus involvement in real world evidence studies.

You will gain exposure to cross-functional interactions with regulatory, clinical development, and commercial teams while contributing to launch readiness for innovative therapies.

Qualifications

• Pursuing a relevant degree (biomed, life science, pharmaceutical science etc.) at the time of application.
• Full-time commitment from Jan to May/Jun.
• Data analytics, video editing and project management experience preferred.

Responsibilities

• Analyze actionable medical insights submitted by the field medical teams on a monthly basis.
• Assist with organizing and rollout of medical education events for health care professionals.
• Project manage internal training programs for medical affairs personnel across the region.
• Literature/desktop reviews to update internal teams on obesity advances.
• Support ongoing real world evidence studies in the region.
• Understand the role of medical affairs within the pharmaceutical industry.
• Collaborate with regulatory affairs, clinical development and commercial operations to ensure launch readiness for innovative therapies.

Skills

Data Analytics

Video Editing

Project Management

Agile mindset

Education

Biomed

Life Science

Pharmaceutical Science

Job description

Boehringer Ingelheim Singapore invites a full-time Contract for Service Intern to support regional medical education events for health care professionals and internal training. The role emphasizes insights analysis and desktop research on obesity, plus involvement in real world evidence studies.

You will gain exposure to cross-functional interactions with regulatory, clinical development, and commercial teams while contributing to launch readiness for innovative therapies.